Commercialization deals News
Most Popular Commercialization deals Story
Glaxo inks $375M epigenetics deal with SuperGen
SuperGen has teamed up with GlaxoSmithKline in a $375 million drug development deal to find new cancer therapies, and investors spurred its shares up by 28 percent on the news. In a deal that is Read more...
Latest Headlines
- October 26, 2009
- August 4, 2009
- December 22, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
